Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.25% | 83.16% | 69.53% | 54.34% | 25.62% |
| Total Depreciation and Amortization | 131.25% | 72.48% | 51.81% | -15.82% | -28.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -94.65% |
| Total Other Non-Cash Items | 6.47% | -42.60% | -35.24% | -26.43% | -35.58% |
| Change in Net Operating Assets | 49.25% | -195.92% | -577.39% | -488.81% | -220.09% |
| Cash from Operations | 104.77% | 80.13% | 63.50% | 28.52% | -35.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.43% | 226.47% | 203.37% | 217.50% | 212.89% |
| Cash from Investing | -65.69% | 226.47% | 203.37% | 217.50% | 211.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 19.07% | 19.07% |
| Issuance of Common Stock | -74.15% | -97.68% | -89.24% | -90.74% | -91.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 788.39% |
| Cash from Financing | -83.97% | -96.96% | -88.20% | -103.69% | -83.77% |
| Foreign Exchange rate Adjustments | 2,394.92% | -328.38% | -240.44% | 182.41% | 109.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.47% | 143.23% | 147.19% | -160.88% | -410.21% |